Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
32,987
Sort by:
Tarceva - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tarceva API intelligence over Tarceva and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tasigna - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tasigna API intelligence over Tasigna and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Taxotere - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Taxotere API intelligence over Taxotere and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tegrital - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tegrital API intelligence over Tegrital and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tekturna - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tekturna API intelligence over Tekturna and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Telavic - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Telavic API intelligence over Telavic and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Telfast - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Telfast API intelligence over Telfast and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Temodar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Temodar API intelligence over Temodar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tenormine - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tenormine API intelligence over Tenormine and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Testogel - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Testogel API intelligence over Testogel and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Thalomide Pharmion - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Thalomide Pharmion API intelligence over Thalomide Pharmion and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tiotropium - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tiotropium API intelligence over Tiotropium and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tobi - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tobi API intelligence over Tobi and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Toprol - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Toprol API intelligence over Toprol and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Toviaz - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Toviaz API intelligence over Toviaz and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tracleer - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tracleer API intelligence over Tracleer and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Treanda - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Treanda API intelligence over Treanda and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Trioptal - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Trioptal API intelligence over Trioptal and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Truvada - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Truvada API intelligence over Truvada and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tygacil - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tygacil API intelligence over Tygacil and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tyvaso - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tyvaso API intelligence over Tyvaso and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tyverb - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tyverb API intelligence over Tyverb and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Ultane - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Ultane API intelligence over Ultane and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Uniflox - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Uniflox API intelligence over Uniflox and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Urinary Incontinence - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Urinary Incontinence Key assessments Patient Segmentation in Urinary Incontinence Urinary Incontinence Risk & Burden Factors driving growth in a specific Urinary Incontinence patient population
January 2022
60 pages
Urinary Incontinence - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Urinary Incontinence Report Assessment Current Treatment Practices in Urinary Incontinence Unmet Needs in Urinary Incontinence Market Attractiveness Market Drivers and Barriers KEY ...
January 2022
200 pages
Urolosin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Urolosin API intelligence over Urolosin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Uveitis - Epidemiology Forecast to 2032
US$ 3,950.00
... epidemiology historical and forecasted data of Uveitis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease ... the global Uveitis market. Identifying prevalent patient populations as well as risk factors in the global Uveitis market ...
January 2022
60 pages
Uveitis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... . Uveitis Report Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Uveitis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs ...
January 2022
200 pages
Velcade - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Velcade API intelligence over Velcade and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Velmetia - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Velmetia API intelligence over Velmetia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Venoferrum - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Venoferrum API intelligence over Venoferrum and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Ventorlin Expectorant - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Ventorlin Expectorant API intelligence over Ventorlin Expectorant and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Veramyst - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Veramyst API intelligence over Veramyst and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Vfend - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Vfend API intelligence over Vfend and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Vidaza - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Vidaza API intelligence over Vidaza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Vimpat - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Vimpat API intelligence over Vimpat and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Viread - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Viread API intelligence over Viread and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Vitiligo - Epidemiology Forecast to 2032
US$ 3,950.00
... epidemiology historical and forecasted data of Vitiligo prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease ... global Vitiligo market. Identifying prevalent patient populations as well as risk factors in the global Vitiligo market ...
January 2022
60 pages
Vitiligo - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Vitiligo Vitiligo Pipeline Analysis Vitiligo Market Size and Trends Vitiligo Market Opportunities Impact of upcoming Therapies in Vitiligo Vitiligo Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Vitiligo Report ...
January 2022
200 pages
Vivacor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Vivacor API intelligence over Vivacor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Vivanza - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Vivanza API intelligence over Vivanza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Volibris - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Volibris API intelligence over Volibris and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Votrient - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Votrient API intelligence over Votrient and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Votubia - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Votubia API intelligence over Votubia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Vyvanse - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Vyvanse API intelligence over Vyvanse and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xanax - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xanax API intelligence over Xanax and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xarelto - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xarelto API intelligence over Xarelto and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xelevia - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xelevia API intelligence over Xelevia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xeloda - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xeloda API intelligence over Xeloda and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
